Dmard

Nearly 40% of children with oligoarticular juvenile idiopathic arthritis treated with intra-articular corticosteroids required no additional therapy, according to data published in Arthritis Research & Therapy.

Gut microbiota profiles in stool samples of patients with rheumatoid arthritis predicted their response to disease-modifying antirheumatic drugs, according to data in Rheumatology.

Among patients with rheumatoid arthritis diagnosed with breast cancer, the utilization of TNF inhibitors and other biologic disease-modifying antirheumatic drugs has not risen for more than a decade, according to data published in Arthritis Care & Research.

In this video, Sebastian E. Sattui, MD, MS, discusses the efforts needed to increase awareness of polymyalgia rheumatica.

SAN DIEGO — TNF inhibitors demonstrate comparable risks for hospitalization and death vs. non-TNF agents in patients with rheumatoid arthritis-associated interstitial lung disease, according to data presented at ACR Convergence 2023.

SAN DIEGO — Split-dose methotrexate had greater efficacy and reduced the need for additional disease-modifying antirheumatic drugs at 16 weeks vs. a single dose for rheumatoid arthritis, according to data presented at ACR Convergence 2023.

Little evidence suggests that any specific biologic or targeted synthetic disease-modifying antirheumatic drug is superior to another for rheumatoid arthritis, highlighting the importance of individualized treatment, according to data.

An automated best practice advisory within the electronic health record can improve infectious disease screening in patients with autoimmune and rheumatic conditions, according to data published in Arthritis Care & Research.

PHILADELPHIA — Patients with psoriatic arthritis who achieved clinical disease control demonstrated clinically meaningful improvements across a broad range of patient-reported outcomes, including pain, fatigue, physical function and work productivity.

PHILADELPHIA — The initiation of disease-modifying antirheumatic drugs among U.S. veterans with active rheumatoid arthritis requires improvement, regardless of rural or urban setting, according to a presentation at ACR Convergence 2022.